4SC AG
Biopharmaceutical company with no products under development or operational business.
VSC | F
Overview
Corporate Details
- ISIN(s):
- DE000A3E5C40
- LEI:
- 391200QOKN7LGVP0RQ86
- Country:
- Germany
- Address:
- Fraunhoferstr. 22, 82152 Planegg
- Website:
- https://www.4sc.com/
- Sector:
- Manufacturing
Description
4SC AG is a biopharmaceutical company that formerly focused on the research and development of small-molecule drugs for cancer treatment. The company's strategy centered on addressing diseases with high unmet medical needs by developing innovative therapies that targeted epigenetic mechanisms of action. According to the company's official statements, it currently has no products under development and no operational business.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2018-01-22 07:30 |
4SC AG strengthens patent protection for its Hedgehog/GLI signaling inhibitor 4…
|
English | HTML • 11.9 KB | ||
| 2018-01-09 07:30 |
4SC AG: 11 upcoming conferences and investor events
|
English | HTML • 14.1 KB | ||
| 2017-12-20 07:30 |
4SC receives Pediatric Investigation Plan Waiver for resminostat in CTCL from t…
|
English | HTML • 13.6 KB | ||
| 2017-12-19 13:34 | English | HTML • 2.1 KB | |||
| 2017-12-19 10:35 | English | HTML • 17.9 KB | |||
| 2017-12-19 00:00 |
Datum:19.12.2017
|
German | HTML • 11.1 KB | ||
| 2017-12-13 07:30 |
4SC receives milestone payment from Immunic
|
English | HTML • 9.2 KB | ||
| 2017-12-05 07:30 |
4SC AG: Significant milestone reached for pivotal RESMAIN study of resminostat …
|
English | HTML • 15.3 KB | ||
| 2017-12-04 08:44 |
DGAP-DD: 4SC AG english
|
English | HTML • 7.2 KB | ||
| 2017-11-07 13:26 |
DGAP-DD: 4SC AG english
|
English | HTML • 7.2 KB | ||
| 2017-11-06 07:30 |
First patient enrolled in Phase Ib/II study SENSITIZE of 4SC-202 in melanoma
|
English | HTML • 15.1 KB | ||
| 2017-11-02 07:30 |
4SC AG: 10 upcoming conferences and investor events
|
English | HTML • 15.5 KB | ||
| 2017-10-26 07:30 |
4SC provides Q3 and 9M 2017 update
|
English | HTML • 17.2 KB | ||
| 2017-10-26 00:00 |
Q3 statement / Q3 financial report 2017
|
English | PDF • 969.9 KB | ||
| 2017-10-10 07:30 |
4SC AG: Resminostat demonstrates potential to significantly alleviate itching i…
|
English | HTML • 15.5 KB |
Automate Your Workflow. Get a real-time feed of all 4SC AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for 4SC AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for 4SC AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
